CBSA delivers awards to top bioscience leaders

Tuesday November 12, 2019 0 comments Tags: Denver, Colorado BioScience Association, Jennifer Jones Paton, Biodesix, Securisyn, Agilent Technologies, TOLMAR, Array BioPharma, Scott Larson

DENVER -- Colorado BioScience Association celebrated the companies and organizations developing life-saving breakthroughs at its Annual Awards Dinner held Nov. 7 at the Hyatt Regency in Denver.

The 16th annual event brought together life sciences leaders and innovators working in Colorado to save and change lives around the world.CBSA-logo-NEW 

“Health innovations from Colorado make a global impact. Our celebration highlighted our life sciences ecosystem’s commitment to sharing opportunities and breakthroughs by our members that save and change lives,” said Jennifer Jones Paton, CBSA president and CEO.

“Congratulations to our honorees, finalists and award winners. They inspire all of us with their passion and dedication.”

Company of the Year: Biodesix

Based in Boulder, Biodesix is providing a more complete picture of a patient’s unique lung cancer by harnessing powerful genomic and proteomic information. The company offers three blood-based, multi-omic tests for patients with lung cancer, using both genomics and proteomics to see both sides of cancer.

Finalists for the award were: Brickell Bio and Cerapedics.

Rising Star of the Year: Securisyn Medical

The Highlands Ranch-based medical device company is dedicated to creating and cultivating an approach to airway management that will enhance airway safety, prevent unplanned extubation and its associated complications.

Finalists for the award were: Bolder Surgical and Edgewise Therapeutics.

Master of Ceremonies Kyle Dyer, along with Jones Paton and CBSA Chairman of the Board Scott Larson, highlighted the celebration’s theme, “Stronger Together” throughout the evening.

They shared stories of ecosystem collaboration and impact on patients’ lives as they honored bold leaders and big thinkers, including:

Educator of the Year: Dr. Chelsea Magin

An assistant professor in medicine and bioengineering at the University of Colorado Anschutz Medical Campus, Magin is an active mentor in Colorado BioScience Institute’s Research Experience for Teachers (RET) program.

Institute Leadership Award: Agilent Technologies and Tolmar

The companies provided leadership and financial support for Frederick High School to establish Pathways in Technology Early College High Schools, or P-TECH. Students in the program graduate in 4-6 years with both a high school diploma and associate’s degree, ready to enter the life sciences workforce.

Deal of the Year: Array Biopharma

This Boulder company grew from an idea to a record-breaking acquisition by a global pharmaceutical manufacturer. The commercial-stage biopharmaceutical company focuses on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases. Earlier this year, Pfizer acquired Array in a deal valued at $11.4 billion.

The evening also included a celebration of life honoring Adam Rubenstein (1970-2019), the former CEO of Articulus Bio and a deeply respected life sciences entrepreneur and mentor.